newsfilter
← Latest News
Business Wire·

Satellos Reports First Quarter 2025 Results and Highlights Recent Company Progress

- Completed enrollment in the Phase 1b trial in adult patients with Duchenne muscular dystrophy (DMD); data analysis and reporting expected in Q2 2025 - Received regulatory approval, allowing initiation of a long-term